| Purity: | >99% |
|---|---|
| Model Number: | CAS No.: 202409-33-4 |
| Brand Name: | Musclesteroids |
| Grade Standard: | Medicine Grade |
| Type: | Auxiliaries and Other Medicinal Chemicals |
| Place of Origin: | China (Mainland) |
| EINECS No.: | 213-988-5 |
| MF: | 202409-33-4 |
| Other Names: | Etoricoxib;5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyr |
| CAS No.: | CAS No.: 202409-33-4 |
| Payment Terms:: | T/T, Western Union, Money Gram |
| Delivery Ways: | EMS, Hkems, TNT, DHL, FedEx, UPS etc. |
| Shipment Time: | 3-5 Working Days After Receiving Payment |
| Usage: | as an antitussive, or cough suppressant. |
Quick Details
Specifications
Product Detail
Basic Info
- Model NO. : *4-187
- Assay: 99%
- Grade Standard: Medicine Grade
- Place of Origin: Xian, China (Mainland)
- Appearance: off-White Powder
- Trademark: wango
- Specification: SGS SO
- Origin: Xian China
Product Description
Cas No. : 202409-33-4 purity 99% Etoricoxib for osteoarthritis
Basic information :
Specification:
Function :
Etoricoxib CAS 202409-33-4 Treatment of osteoarthritis of the signs and symptoms of acute and chronic phase
Basic information :
|
CAS No. : |
202409-33-4 |
Other Names: |
Etoricoxib |
MF: |
Etoricoxib |
|
EINECS No. : |
202409-33-4 Etoricoxib |
Place of Origin: |
Shanxi , China (Mainland) |
Type: |
Antipyretic Analgesics and NSAIDs, 202409-33-4 Etoricoxib |
|
Grade Standard: |
Medicine Grade |
Brand Name: |
Wango |
Model Number: |
API-Etoricoxib |
|
Purity: |
99% Etoricoxib |
USAGE: |
Pharmaceutical raw materials |
Appearance: |
Etoricoxib powder |
|
COA: |
Available |
MSDS: |
Available |
Spectrum: |
Available |
|
Inventory status: |
In stock |
Assay: |
99% min |
Shelf life: |
2 years |
Specification:
| Synonyms | Etoricoxib; 5-Chloro-6'-methyl-3-[4-(methylsulfonyl)phenyl]-2,3'-bipyridine |
| Category | Pharmaceutical Raw Materials, Active Pharmaceutical Ingredients, Bulk Drugs, Fine Chemicals. |
| Standard | Purity: > 99% |
| Appearance | Etoricoxib powder |
| Shelf life | 2 years |
| Usage |
Etoricoxib is indicated for the treatment of rheumatoid arthritis, psoriatic arthritis, osteoarthritis, ankylosing spondylitis, chronic low back pain, acute pain, and gout. |
|
Storage |
Etoricoxib should be stored in a well-closed container at low temperature, keep away from moisture, heat and light |
Function :
Etoricoxib CAS 202409-33-4 Treatment of osteoarthritis of the signs and symptoms of acute and chronic phase
|
|
|
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|||
|
|
|||
|
|
|||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||
|
|
|
||